期刊文献+

Flavopiridol诱导多发性骨髓瘤细胞凋亡的分子机制 被引量:3

Molecular mechanisms of flavopiridol in inducing apoptosis in multiple myeloma
下载PDF
导出
摘要 目的探讨flavopiridol诱导多发性骨髓瘤(MM)细胞凋亡的分子机制。方法以TUNEL法检测细胞凋亡,Western blot测定Mcl-1、CyclinD2、Bcl-XL、Bag-1和XIAP等。结果在临床剂量的flavopiridol浓度下,MM细胞系在加药后3 h内出现快速凋亡。不同剂量的flavopiridol均可快速诱导Mcl-1表达下调和CTD磷酸化的抑制,flavopiridol抑制CTD磷酸化的剂量与其抑制Mcl-1表达的剂量密切相关。该剂量也是其诱导MM细胞凋亡的剂量。转录抑制因子放线菌素D及flavopiridol均能抑制Mcl-1表达,并可诱导原代MM细胞凋亡。结论转录抑制因子放线菌素D和CDK抑制剂flavopiridol诱导MM细胞凋亡可能与其抑制CTD磷酸化,从而抑制Mcl-1的mRNA以及蛋白质水平有关。 Objective To study the molecular mechanisms of flavopiridol in inducing apoptosis in multiple myeloma(MM).Methods TUNEL methods were used to detect cell apoptosis;Western blot was used to determine the expression levels of myeloid cell leukemia-1(Mcl-1),CyclinD2,Bcl-XL,Bag-1 and XIAP.Results The clinical concentration of flavopiridol resulted in rapid apoptosis after dosing within 3h in MM cell lines.Different doses of flavopiridol could induce rapid down-expression of Mcl-1 and inhibition of CTD phosphorylation.The dose of flavopiridol's inhibition on CTD phosphorylation was closely related to the dose of its inhibition on Mcl-1 expression.This dose was also the one that induced apoptosis in MM cells.Transcription inhibitor actinomycin D and flavopiridol could also inhibit the expression of Mcl-1 and induce apoptosis in primary MM.Conclusion Apoptosis of myeloma cells induced by transcription inhibitor actinomycin D and CDK inhibitor flavopiridol may be related to their inhibition on CTD phosphorylation,thereby inhibiting Mcl-1 at the mRNA and protein levels.
作者 王孟昌 张斌
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2011年第2期201-204,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.81071952)~~
关键词 多发性骨髓瘤 FLAVOPIRIDOL MCL-1 BCL-XL BAG-1 CYCLIND2 multiple myeloma flavopiridol Mcl-1 Bcl-XL Bag-1 CyclinD2
  • 相关文献

参考文献11

  • 1SIROHI B,POWLES R.Multiple myeloma[J].Lancet,2004,363(9412):875-887.
  • 2VAN DE DONK NW,BLOEM AC,VAN DER SPEK E,et al.New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway[J].Curr Pharm Des,2006,12(3):327-340.
  • 3LE GOUILL S,PODAR K,HAROUSSEAU JL,et al.Mcl-1 regulation and its role in multiple myeloma[J].Cell Cycle,2004,3(10):1259-1262.
  • 4ZHANG B,GOJO I,FENTON RG.Myeloid cell factor-1 is a critical survival factor for multiple myeloma[J].Blood,2002,99(6):1885-1893.
  • 5PATHAK AK,BHUTANI M,NAIR AS,et al.Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells[J].Mol Cancer Res,2007,5(9):943-955.
  • 6OPFERMAN JT.Life and death during hematopoietic differentiation[J].Curr Opin Immunol,2007,19(5):497-502.
  • 7AKGUL C.Mcl-1 is a potential therapeutic target in multiple types of cancer[J].Cell Mol Life Sci,2009,66(8):1326-1336.
  • 8WU K,WANG C,D'AMICO M,et al.Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells:association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways[J].Mol Cancer Ther,2002,1(9):695-706.
  • 9KRYSTOF V,ULDRIJAN S.Cyclin-dependent kinase inhibitors as anticancer drugs[J].Curr Drug Targets,2010,11(3):291-302.
  • 10DISPENZIERI A,GERTZ MA,LACY MQ,et al.Flavopiridol in patients with relapsed or refractory multiple myeloma:a phase 2 trial with clinical and pharmacodynamic end-points[J].Haematologica,2006,91(3):390-393.

同被引文献33

  • 1俞琦,蔡琨,田维毅.白蔹醇提物免疫活性的初步研究[J].贵阳中医学院学报,2005,27(2):20-21. 被引量:10
  • 2俞文胜,陈新民,杨磊.白蔹多酚类化学成分的研究(Ⅱ)[J].中药材,1995,18(6):297-301. 被引量:15
  • 3郭丽冰,卢雁,陈水平.白蔹化学成分的研究[J].广东药学院学报,1996,12(3):145-147. 被引量:20
  • 4金永焕.高压氧早期治疗颅脑损伤疗效观察[J].吉林大学学报(医学版),2006,32(6):1115-1115. 被引量:1
  • 5李洪娟,张蕾,王术光.白蔹的药理作用及临床应用[J].食品与药品,2007,9(10A):60-62. 被引量:18
  • 6Lee DK, Kim B, Lee SG, et al. Momordins inhibit both AP-I fimction and cell proliferation [J]. Anticancer Res, 1998, 18 ( 1A ) : 119-124.
  • 7Sun L, Zhou W, Mueller C, et al. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia [J]. J Cereb Blood Flow Metab, 2010, 30 (9): 1651-1660.
  • 8Yang ZJ, Xie Y, Bosco GM, et al. Hyperbaric oxygenation alleviates MCAO induced brain injury and reduces hydroxyl radical formation and glutamate release [J]. Eur J Appl Physiol, 2010, 108 (3): 513-522.
  • 9Soejima Y, Ostrowski RP, Manaenko A, et al. Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats [J]. Med Gas Res, 2012 April 11. doi.- 10. 1186/2045-9912 2 9.
  • 10Miehalski D, H/irtig W, Schneider D, et al. Use of normobaric and hyperbaric oxygen in acute focal cerebral ischemia a preelinical and clinical review [J]. Acta Neurol Scand, 2011, 123 (2):85-97.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部